177 related articles for article (PubMed ID: 32748814)
21. The ameliorated longevity and pharmacokinetics of valsartan released from a gel system of ultradeformable vesicles.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1457-63. PubMed ID: 25953248
[TBL] [Abstract][Full Text] [Related]
22. Spanlastics gel-A novel drug carrier for transdermal delivery of glimepiride.
Elsaied EH; Dawaba HM; Ibrahim ESA; Afouna MI
J Liposome Res; 2023 Mar; 33(1):102-114. PubMed ID: 35862551
[TBL] [Abstract][Full Text] [Related]
23. Effect of the Dispersion States of Azone in Hydroalcoholic Gels on Its Transdermal Permeation Enhancement Efficacy.
Chen HL; Cai CC; Ma JY; Yu ML; Zhao MH; Guo JB; Xu H
J Pharm Sci; 2018 Jul; 107(7):1879-1885. PubMed ID: 29518401
[TBL] [Abstract][Full Text] [Related]
24. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
Expert Opin Drug Deliv; 2014 Aug; 11(8):1149-62. PubMed ID: 24830648
[TBL] [Abstract][Full Text] [Related]
25. Lornoxicam controlled release transdermal gel patch: Design, characterization and optimization using co-solvents as penetration enhancers.
Hashmat D; Shoaib MH; Ali FR; Siddiqui F
PLoS One; 2020; 15(2):e0228908. PubMed ID: 32107483
[TBL] [Abstract][Full Text] [Related]
26. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
Singh S; Gajra B; Rawat M; Muthu MS
Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
[TBL] [Abstract][Full Text] [Related]
27. Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer.
Vora D; Dandekar A; Bhattaccharjee S; Singh ON; Agrahari V; Peet MM; Doncel GF; Banga AK
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336054
[TBL] [Abstract][Full Text] [Related]
28. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
29. Assessing the Efficacy of Berberine Hydrochloride-loaded Transethosomal Gel System in Treating Dermatophytosis Caused by Trichophyton Rubrum in ex-vivo, in-vitro, and in-vivo models.
Mishra KK; Kaur CD; Singh S; Tiwari A; Tiwari V; Sharma A
Curr Drug Res Rev; 2023 Jul; ():. PubMed ID: 37496248
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronic acid gel-core liposomes (hyaluosomes) enhance skin permeation of ketoprofen.
Kawar D; Abdelkader H
Pharm Dev Technol; 2019 Oct; 24(8):947-953. PubMed ID: 30676142
[TBL] [Abstract][Full Text] [Related]
31. Low-Frequency Sonophoresis as an Active Approach to Potentiate the Transdermal Delivery of Agomelatine-Loaded Novasomes: Design, Optimization, and Pharmacokinetic Profiling in Rabbits.
Tawfik MA; Mohamed MI; Tadros MI; El-Helaly SN
AAPS PharmSciTech; 2021 Oct; 22(8):261. PubMed ID: 34705130
[TBL] [Abstract][Full Text] [Related]
32. Role of simplex lattice statistical design in the formulation and optimization of microemulsions for transdermal delivery.
Duangjit S; Mehr LM; Kumpugdee-Vollrath M; Ngawhirunpat T
Biol Pharm Bull; 2014; 37(12):1948-57. PubMed ID: 25590086
[TBL] [Abstract][Full Text] [Related]
33. Development of Hydrogels for Microneedle-Assisted Transdermal Delivery of Naloxone for Opioid-Induced Pruritus.
Gao X; Brogden NK
J Pharm Sci; 2019 Nov; 108(11):3695-3703. PubMed ID: 31476312
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic insights into high permeation vesicle-mediated synergistic enhancement of transdermal drug permeation.
Jain S; Khare P; Date T; Katiyar SS; Kushwah V; Katariya MK; Swami R
Nanomedicine (Lond); 2019 Aug; 14(16):2227-2241. PubMed ID: 31397197
[No Abstract] [Full Text] [Related]
35. Transdermal lipid vesicular delivery of iloperidone: Formulation, in vitro and in vivo evaluation.
Londhe VY; Bhasin B
Colloids Surf B Biointerfaces; 2019 Nov; 183():110409. PubMed ID: 31386933
[TBL] [Abstract][Full Text] [Related]
36. Formulation and evaluation of proniosomes containing lornoxicam.
Madan JR; Ghuge NP; Dua K
Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
[TBL] [Abstract][Full Text] [Related]
37. A transdermal delivery system for glipizide.
Ammar HO; Salama HA; Ghorab M; El-Nahhas SA; Elmotasem H
Curr Drug Deliv; 2006 Jul; 3(3):333-41. PubMed ID: 16848735
[TBL] [Abstract][Full Text] [Related]
38. Penetration enhancers in proniosomes as a new strategy for enhanced transdermal drug delivery.
El Maghraby GM; Ahmed AA; Osman MA
Saudi Pharm J; 2015 Jan; 23(1):67-74. PubMed ID: 25685045
[TBL] [Abstract][Full Text] [Related]
39. Tailoring of Novel Bile Salt Stabilized Vesicles for Enhanced Transdermal Delivery of Simvastatin: A New Therapeutic Approach against Inflammation.
Khafagy ES; Almutairy BK; Abu Lila AS
Polymers (Basel); 2023 Jan; 15(3):. PubMed ID: 36771977
[TBL] [Abstract][Full Text] [Related]
40. Enhance transdermal delivery of flurbiprofen via microemulsions: Effects of different types of surfactants and cosurfactants.
Idrees M; Rahman N; Ahmad S; Ali M; Ahmad I
Daru; 2011; 19(6):433-9. PubMed ID: 23008689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
